PI 3-kinase inhibitors and methods of their use

Details for Australian Patent Application No. 2008213808 (hide)

International Classifications

Event Publications

6 August 2009 PCT application entered the National Phase

PCT publication WO2008/098058 Priority application(s): WO2008/098058

24 September 2009 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the Name Novartis Vaccines and Diagnostics, Inc., Application No. 2008213808, under INID (54) correct the title to read PI 3-kinase inhibitors and methods of their use Corrigenda

5 November 2009 Amendment Made

The nature of the amendment is: Amend the applicant name from Novartis Vaccines and Diagnostics, Inc. to Novartis AG

10 November 2011 Application Accepted

Published as AU-B-2008213808

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.